Corcept Therapeutics Inc Asset Turnover Ratio (CORT), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Corcept Therapeutics Inc  (NASDAQ: CORT)
 

Corcept Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Corcept Therapeutics Inc asset turnover ratio, the ability of Corcept Therapeutics Inc's assets to generate revenue in the second quarter 2026, increased sequentially to 0.99 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as CORT's position remain challenging.

Within sector 29 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 676 to 846.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORT Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 8.44 % -3.73 % 18.32 % 25.7 % 33.7 %
Y / Y Revenue Change 31.74 % 4.89 % 11.12 % 13.75 % 18.7 %
Asset Turnover Ratio (TTM) 0.99 0.94 0.92 0.93 0.95
CORT's Total Ranking # 846 # 676 # 945 # 918 # 1041
Seq. Asset Change 6.69 % -2.6 % 1.58 % 2.73 % -5.28 %
Seq. Revenue Change 55.33 % -18.42 % -2.66 % 6.79 % 23.67 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 78
Overall Market # 846

Asset Turnover Ratio Statistics
High Average Low
15.6 12.35 8.53
(Sep 30 2020)   (Sep 30 2013)




CORT Company Profile • Back to CORT Efficiency Comparisons • Compare CORT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
P3 Health Partners Inc   2.25 $ 1,502.838  Millions$ 667.189  Millions
Vycor Medical Inc   2.10 $ 1.807  Millions$ 0.860  Millions
Biofrontera Inc   1.98 $ 45.956  Millions$ 23.207  Millions
International Stem Cell Corporation  1.88 $ 9.514  Millions$ 5.073  Millions
Iridex Corp  1.81 $ 51.044  Millions$ 28.259  Millions
Progyny Inc   1.78 $ 1,311.298  Millions$ 737.959  Millions
Cv Sciences Inc   1.77 $ 12.066  Millions$ 6.800  Millions
Chemed Corporation  1.65 $ 2,595.001  Millions$ 1,569.302  Millions
Aspira Women s Health inc   1.62 $ 9.029  Millions$ 5.569  Millions
Adm Tronics Unlimited Inc   1.59 $ 3.240  Millions$ 2.034  Millions
Lftd Partners Inc   1.56 $ 35.335  Millions$ 22.674  Millions
Nephros Inc   1.54 $ 21.686  Millions$ 14.113  Millions
Medinotec Inc   1.52 $ 10.247  Millions$ 6.745  Millions
Marpai Inc  1.51 $ 16.635  Millions$ 11.010  Millions
Meiragtx Holdings Plc  1.48 $ 397.501  Millions$ 268.751  Millions
Evofem Biosciences Inc   1.47 $ 18.045  Millions$ 12.261  Millions
Infusystem Holdings Inc  1.45 $ 143.335  Millions$ 98.950  Millions
Medpace Holdings Inc   1.41 $ 2,782.288  Millions$ 1,978.819  Millions
Avita Medical Inc   1.38 $ 75.631  Millions$ 54.860  Millions
Edap Tms Sa  1.37 $ 111.051  Millions$ 81.022  Millions
Idexx Laboratories Inc  1.34 $ 4,553.792  Millions$ 3,391.326  Millions
Vaxart Inc   1.31 $ 243.064  Millions$ 185.077  Millions
Karyopharm Therapeutics Inc   1.31 $ 146.621  Millions$ 111.845  Millions
Aveanna Healthcare Holdings Inc   1.31 $ 2,602.820  Millions$ 1,987.815  Millions
Tactile Systems Technology Inc   1.29 $ 350.319  Millions$ 271.226  Millions
Lifeloc Technologies Inc   1.29 $ 9.269  Millions$ 7.201  Millions
Precipio inc   1.29 $ 27.198  Millions$ 21.149  Millions
Interpace Biosciences Inc   1.28 $ 36.519  Millions$ 28.458  Millions
Exagen Inc   1.27 $ 71.427  Millions$ 56.184  Millions
Electromed Inc   1.24 $ 72.076  Millions$ 58.289  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.